Australia's Nanoveu eyes best day in more than a week on patent approval

Nanoveu

19/11/2021 03:39

** Shares of Australia's Nanoveu Ltd  NVU.AX  rise as much
as 15.8% to A$0.044 after co says it received patent approval
for its EyeFyx product
    ** Nanotechnology co says patent approval gives intellectual
property rights in 18 countries including the United States,
Japan, China and Australia, and in Europe  urn:newsml:reuters.com:*:nASX96FbY6 
    ** EyeFyx is a vision correction solution that manipulates
screen output which addresses long-sightedness without reading
glasses
    ** Stock rises by the most since Nov. 9, hits highest level
since Nov. 9    
    ** NVU down 41.5% year-to-date, as of last close 

 (Reporting by Harshita Swaminathan in Bengaluru)
 ((Harshita.Swaminathan@thomsonreuters.com))